Open AccessA Comparison of US Clinical Laboratory Chlamydia and Gonorrhea Testing Practices Before and After the 2014 Centers for Disease Control and Prevention Testing Recommendations
Author(s) -
Alissa Davis,
Anne Gaynor
Publication year - 2020
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001299
Subject(s) - medicine , chlamydia trachomatis , gonorrhea , nucleic acid amplification tests , neisseria gonorrhoeae , chlamydia , disease control , sexually transmitted disease , disease , chlamydial infection , gynecology , family medicine , virology , syphilis , immunology , microbiology and biotechnology , human immunodeficiency virus (hiv) , biology
Adherence to recommended laboratory testing practices is crucial for sexually transmitted infection prevention and control. The objective of this article is to compare Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing practices of US clinical laboratories in 2013 before the updated 2014 Centers for Disease Control and Prevention recommendations and in 2015 after the updated recommendations.